Did you mean
modification

Search results - 27 results

Engineering nucleases for gene targeting: safety and regulatory considerations.

available about off-target effects associated with the use of this approach. We discuss how NBGT may offer a new perspective for genetic modification, we address some aspects crucial for a safety improvement ...

Event report: SynBio Workshop (Paris 2012)- Risk assessment challenges of Synthetic Biology

Discussion Emerging risks Europe European European Commission European countries Field food Food Safety genetic modification GMOs health identify INFORMATION Institute International journal Monitoring national ...

Chlamydia Psittaci, Causative Agent of Avian Chlamydiosis and Human Psittacosis: Risk Assessment and Biosafety Recommendations for Laboratory Use

Volume 17, Issue 2, Number 88, p.82- 88 (2012) Keywords: Abattoirs Agent article AS assessment bacteria biosafety cell culture cells CONTACT containment disease environment general genetic modification ...

Motif switches: decision-making in cell regulation.

These interactions underlie the ability of proteins to make decisions by combining regulatory information encoded in a protein’s expression level, localisation and modification state. This raises the ...

Guidelines for Independent Lot Release of Vaccines by Regulatory Authorities

requirements, or modifications may be justified and made by a national regulatory authority. It is recommended that modifications to the principles and technical specifications of these guidelines be made only on ...

Population pharmacokinetic modeling and optimal sampling strategy for Bayesian estimation of amikacin exposure in critically ill septic patients88

Toxicology treatment Volume Abstract: Because the sepsis-induced pharmacokinetic (PK) modifications need to be considered in aminoglycoside dosing, the present study aimed to develop a population PK model for ...

New techniques of genetic modification and the GMO definition

146, Brussels, p.144- 146 (2010) Keywords: a AS at biosafety Biotechnology challenge Context definition European European Union Genetic genetic modification genetically Genetically modified Genetically ...

Design, synthesis and pharmacological characterization of endomorphin analogues with non-cyclic amino acid residues in position 24386

potency than EM-2 which confirmed the usefulness of structural modifications in obtaining new leads for pain-relief therapeutics Service:  Quality of laboratories Kwaliteit van laboratoria Qualité des ...

Citrullination of CXCL12 differentially reduces CXCR4 and CXCR7 binding with loss of inflammatory and anti-HIV-1 activity via CXCR4

mechanism to regulate inflammation. In this study, we describe modification of the CXC chemokine stromal cell-derived factor 1alpha/ CXCL12 by peptidylarginine deiminase (PAD) that converts arginine residues ...

QR code

QR code for this page URL